Screener
Janux Therapeutics JANX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$21.97M+35.1% | -$24.36M-3.6% | -$31.95M-58.0% | -$24.31M+13.4% | -$33.86M-468% | ||
| $463K-14.4% | $469K-9.6% | $468K-8.6% | $501K-1.8% | $541K+6.9% | ||
| $3.78M-31.2% | $9.27M-13.4% | $9.52M+52.2% | $9.04M-41.2% | $5.49M-4.7% | ||
| $12.48M+152% | -$12.34M+27.5% | -$28.54M-70.7% | -$12.86M-476% | -$23.81M-138% | ||
| $202K-57.3% | $273K-26.4% | $106K+152% | $93K+272% | $473K+398% | ||
| -$38.78M— | $8.29M+102% | —— | —— | —— | ||
| $2.24M+135% | $3.55M+540% | $2.94M-99.2% | $493K-70.1% | $954K-65.5% | ||
| -$24.06M-13.0% | -$506K+99.9% | $0-100% | -$4.06M-134% | -$21.3M+89.3% |
FAQ
- How much cash does Janux Therapeutics generate?
- Janux Therapeutics (JANX) generated -$41.3M in operating cash flow over the trailing twelve months.
- What is Janux Therapeutics's free cash flow?
- After $674.0K of capital expenditures, Janux Therapeutics's free cash flow was -$41.9M over the trailing twelve months, up 30.9% year over year.
- Where does Janux Therapeutics's cash flow data come from?
- Every line is extracted from Janux Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
